BioCentury
ARTICLE | Company News

Supernus, Actavis Inc. neurology news

July 15, 2013 7:00 AM UTC

Supernus received a Paragraph IV notification letter from Actavis, formerly known as Watson Pharmaceuticals Inc., indicating that Actavis submitted an ANDA to FDA for a generic version of Supernus' ...